Description: SpectraCure AB (publ) focuses on cancer treatment utilizing laser light sources and photo reactive drugs. It develops IDOSE software with interstitial photodynamic therapy system, which is in Phase II clinical trial for the treatment of solid tumors. The company was founded in 2003 and is based in Lund, Sweden.
Home Page: www.spectracure.com
Gasverksgatan 1
Lund,
222 29
Sweden
Phone:
46 46 16 20 70
Officers
| Name | Title |
|---|---|
| Mr. Johan Folkunger | Chief Exec. Officer |
| Mr. Henrik Ljung | Chief Financial Officer |
| Dr. Johannes Swartling Ph.D. | Technical Mang. |
| Ms. Mirjam Johansson | Admin. Mang. |
| Ms. Kristina Holst | Head of Clinical Affairs |
Exchange: ST
Country: SE : Sweden
Currency: Swedish krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.214 |
| Price-to-Sales TTM: | 396.8623 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 15 |